v3.26.1
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Jun. 27, 2026
Jun. 28, 2025
Dec. 31, 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Asset impairment $ 13,037 $ 0 $ 13,037 $ 0  
BioNova | SWEN Impact Fund for Transition 3          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Shares funded (in shares)         111,111
Noncontrolling percentage         14.00%